✅ #FIGARO-DKD trial: finerenone reduces the risk of #cardiovascular morbidity and mortality in patients with mild-to-moderate kidney disease and type 2 #diabetes

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫